Global Partners L.P. (GLP)
Market Open
23 Jul, 18:49
NYSE NYSE Primary $
48. 48
-0.59
-1.2024%
$
1.62B Market Cap
12.15 P/E Ratio
2.38% Div Yield
21,226 Volume
3.9 Eps
$ 49.07
Previous Close 
Want to track GLP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
Wegovy and Zepbound are two of the hottest GLP-1 drugs available on the market right now. The field, however, could become more crowded as more companies develop rival treatments.
Fool | 2 years ago
